Indeed, we show that combined inhibition of BRD4 and IL6/8-JAK2 signaling is required to inhibit oncogene expression more completely, reversed the BETi resistance in vitro, and suppress the CRC xenograft tumor growth empowered by CAF in vivo. This evidence concerns the gene BRD4 and colorectal carcinoma.